96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (11) , 1529-1533
- https://doi.org/10.1016/0277-5379(89)90293-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinomaCancer, 1988
- The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancerCancer, 1986
- A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neckCancer, 1985
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancerCancer, 1982
- Cisplatin-Induced AnemiaNew England Journal of Medicine, 1980
- Cisplatin-Induced HemolysisNew England Journal of Medicine, 1980
- Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusionCancer, 1979
- Combination therapy of advanced head and neck cancer.Induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapyCancer, 1978
- Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusionCancer, 1977